Orbimed Advisors LLC Adicet Bio, Inc. Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 11,447,140 shares of ACET stock, worth $11.4 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
11,447,140
Previous 11,447,140
-0.0%
Holding current value
$11.4 Million
Previous $16.5 Million
33.33%
% of portfolio
0.3%
Previous 0.39%
Shares
6 transactions
Others Institutions Holding ACET
# of Institutions
71Shares Held
59MCall Options Held
7.3KPut Options Held
39.3K-
Tang Capital Management LLC San Diego, CA8.15MShares$8.15 Million0.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$7.54 Million0.12% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$3.75 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$3.21 Million0.0% of portfolio
-
Carlyle Group Inc. Washington, DC2.95MShares$2.95 Million2.83% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $40M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...